Register information Patent

DE file number : 60 2017 053 767.5 (Status: pending/in force, Query started: May 1, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2017 053 767.5
96EP file numberEAKZ17 80 0311.7
86WO file numberWAKZPCT/US2017/033690
97EP publication numberEPN3458054
87WO publication numberWPN2017201502
54Designation/titleTIVERWENDUNG VON GLUTAMATMODULATOREN MIT IMMUNTHERAPIEN ZUR BEHANDLUNG VON KREBS
51IPC main classICM
(ICMV)		 A61K 31/428 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 C07D 277/82 (2006.01)
22DE application dateDATMay 19, 2017
96EP application dateEATMay 19, 2017
86WO application dateWATMay 19, 2017
43Date of first publicationOTNov 23, 2017
Date of publication of grantPETFeb 23, 2022
71/73Applicant/ownerINHBiohaven Therapeutics Ltd., New Haven, CT, US
72InventorINCORIC, Vladimir, New Haven Connecticut 06520, US
Address for service Marks & Clerk (Luxembourg) LLP, 1017 LUXEMBOURG, LU
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201662339433 P
May 20, 2016
Due dateFT
FG		May 31, 2026
Annual fee for the 10th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003458054A1
Searchable text: EP000003458054A1
Original document: EP000003458054B1
Searchable text: EP000003458054B1
Original document: WO002017201502
Searchable text: WO002017201502
43Date of first publicationEVTNov 23, 2017
Date of the first transfer into DPMAregisterEREGTMar 27, 2019
Date of the (most recent) update in DPMAregisterREGTApr 2, 2025
(Show all update days)(Hide all update days)
  • Apr 2, 2025
    • Due date: changed
  • Sep 26, 2024
    • St.36: changed (technical change)
  • Jun 7, 2024; May 16, 2024; Apr 6, 2024; Mar 25, 2023; Feb 2, 2023; Jan 12, 2023; May 7, 2022; Apr 13, 2022; Mar 17, 2022; Feb 9, 2022; Feb 3, 2022; Aug 8, 2019
    • Historical data not available for this/these date(s)
  • Mar 27, 2019
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Nov 23, 2017  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Mar 27, 2019  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA May 9, 2019 May 9, 2019 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Feb 23, 2022  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Mar 17, 2022 Mar 17, 2022 Details anzeigen
6 New applicant/owner details New applicant/owner details Apr 12, 2022  Details anzeigen
7 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Nov 24, 2022 Feb 16, 2023 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTNov 23, 2017
Date of update of the procedureREGTFeb 3, 2022
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTMar 27, 2019
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTMay 9, 2019
Issue numberHN19
YearPJ2019
Publication dateVTMay 9, 2019
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTFeb 23, 2022
Date of update of the procedureREGTFeb 3, 2022
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTMar 17, 2022
Issue numberHN11
YearPJ2022
Publication dateVTMar 17, 2022
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTMar 17, 2022
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTApr 12, 2022
71/73Previous applicant/ownerINHFBiohaven Pharmaceutical Holding Company Ltd., New Haven, CT, US
Date of update of the procedureREGTApr 13, 2022
View procedures Procedure relating to EP application (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTNov 24, 2022
Issue numberHN7
YearPJ2023
Publication dateVTFeb 16, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTFeb 2, 2023